CTMX
CTMX
US23284F1057
CytomX Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
560M EUR
817.12M EUR
1.02B EUR
724.99M EUR
Enterprise Value
213.64M EUR
805.6M EUR
997.19M EUR
716.57M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.43x
--
--
--
Price to Sales
30.6x
44.65x
28.79x
28.67x
Price to Book
1.85x
2.71x
3.2x
7.32x
EV/Revenue
11.67x
44.02x
28.06x
28.34x
EV/EBITDA
-2.48x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-13.43%
-10.09%
-7.84%
-7.54%
ende